Veracyte EBITDA Margin 2012-2025 | VCYT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Veracyte (VCYT) over the last 10 years. The current EBITDA margin for Veracyte as of March 31, 2025 is .
| Veracyte EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.46B | $0.05B | 9.94% |
| 2024-12-31 | $0.45B | $0.04B | 8.74% |
| 2024-09-30 | $0.43B | $0.00B | 0.00% |
| 2024-06-30 | $0.40B | $-0.04B | -10.53% |
| 2024-03-31 | $0.38B | $-0.05B | -14.13% |
| 2023-12-31 | $0.36B | $-0.06B | -16.11% |
| 2023-09-30 | $0.34B | $-0.03B | -8.19% |
| 2023-06-30 | $0.33B | $-0.01B | -2.13% |
| 2023-03-31 | $0.31B | $-0.01B | -3.22% |
| 2022-12-31 | $0.30B | $-0.02B | -5.05% |
| 2022-09-30 | $0.28B | $-0.02B | -7.75% |
| 2022-06-30 | $0.27B | $-0.03B | -11.19% |
| 2022-03-31 | $0.25B | $-0.03B | -11.60% |
| 2021-12-31 | $0.22B | $-0.06B | -28.77% |
| 2021-09-30 | $0.19B | $-0.06B | -33.69% |
| 2021-06-30 | $0.16B | $-0.05B | -34.18% |
| 2021-03-31 | $0.12B | $-0.06B | -48.39% |
| 2020-12-31 | $0.12B | $-0.03B | -22.88% |
| 2020-09-30 | $0.11B | $-0.03B | -24.78% |
| 2020-06-30 | $0.11B | $-0.03B | -23.89% |
| 2020-03-31 | $0.12B | $-0.02B | -16.39% |
| 2019-12-31 | $0.12B | $-0.01B | -9.09% |
| 2019-09-30 | $0.12B | $-0.01B | -5.13% |
| 2019-06-30 | $0.11B | $-0.01B | -7.34% |
| 2019-03-31 | $0.10B | $-0.01B | -10.78% |
| 2018-12-31 | $0.09B | $-0.02B | -19.57% |
| 2018-09-30 | $0.09B | $-0.02B | -24.42% |
| 2018-06-30 | $0.08B | $-0.02B | -28.40% |
| 2018-03-31 | $0.08B | $-0.02B | -31.58% |
| 2017-12-31 | $0.07B | $-0.02B | -31.94% |
| 2017-09-30 | $0.07B | $-0.02B | -30.00% |
| 2017-06-30 | $0.07B | $-0.02B | -28.17% |
| 2017-03-31 | $0.07B | $-0.02B | -35.29% |
| 2016-12-31 | $0.07B | $-0.03B | -39.39% |
| 2016-09-30 | $0.06B | $-0.03B | -50.00% |
| 2016-06-30 | $0.06B | $-0.04B | -65.45% |
| 2016-03-31 | $0.05B | $-0.04B | -67.31% |
| 2015-12-31 | $0.05B | $-0.03B | -69.39% |
| 2015-09-30 | $0.05B | $-0.03B | -72.34% |
| 2015-06-30 | $0.05B | $-0.03B | -73.33% |
| 2015-03-31 | $0.04B | $-0.03B | -73.81% |
| 2014-12-31 | $0.04B | $-0.03B | -78.95% |
| 2014-09-30 | $0.03B | $-0.03B | -84.85% |
| 2014-06-30 | $0.03B | $-0.03B | -89.66% |
| 2014-03-31 | $0.03B | $-0.03B | -100.00% |
| 2013-12-31 | $0.02B | $-0.02B | -109.09% |
| 2013-06-30 | $0.01B | $-0.02B | -141.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.414B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.063B | 22.15 |
| Intuitive Surgical (ISRG) | United States | $172.911B | 71.67 |
| IDEXX Laboratories (IDXX) | United States | $53.117B | 55.28 |
| Edwards Lifesciences (EW) | United States | $45.606B | 30.23 |
| Alcon (ALC) | Switzerland | $42.656B | 28.83 |
| IQVIA Holdings (IQV) | United States | $32.339B | 18.27 |
| DexCom (DXCM) | United States | $31.357B | 47.03 |
| Mettler-Toledo (MTD) | United States | $27.274B | 32.37 |
| STERIS (STE) | Ireland | $24.334B | 25.90 |
| Waters (WAT) | United States | $17.669B | 24.27 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.740B | 0.00 |
| Hologic (HOLX) | United States | $15.342B | 16.62 |
| Penumbra (PEN) | United States | $10.038B | 73.33 |
| Sysmex ADR (SSMXY) | Japan | $8.699B | 27.64 |
| Globus Medical (GMED) | United States | $8.500B | 19.56 |
| Masimo (MASI) | United States | $8.473B | 28.51 |
| Teleflex (TFX) | United States | $5.432B | 8.77 |
| Glaukos (GKOS) | United States | $5.264B | 0.00 |
| TransMedics (TMDX) | United States | $4.501B | 68.42 |
| Integer Holdings (ITGR) | United States | $3.839B | 19.16 |
| LivaNova (LIVN) | United Kingdom | $2.897B | 16.58 |
| Alphatec Holdings (ATEC) | United States | $2.338B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.247B | 0.00 |
| Artivion (AORT) | United States | $2.063B | 104.12 |
| Nihon Kohden (NHNKY) | Japan | $2.052B | 24.49 |
| Elekta AB (EKTAY) | Sweden | $1.874B | 16.84 |
| Pulse Biosciences (PLSE) | United States | $1.130B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.100B | 6.30 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| IRadimed (IRMD) | United States | $0.903B | 43.83 |
| Tandem Diabetes Care (TNDM) | United States | $0.752B | 0.00 |
| AxoGen (AXGN) | United States | $0.679B | 0.00 |
| SiBone (SIBN) | United States | $0.677B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.656B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.552B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.527B | 4.23 |
| OrthoPediatrics (KIDS) | United States | $0.504B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.499B | 8.81 |
| Treace Medical Concepts (TMCI) | United States | $0.436B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.389B | 92.58 |
| Pacific Biosciences Of California (PACB) | United States | $0.384B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.381B | 9.69 |
| AngioDynamics (ANGO) | United States | $0.368B | 0.00 |
| RxSight (RXST) | United States | $0.340B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.339B | 0.00 |
| NeuroPace (NPCE) | United States | $0.308B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.290B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.289B | 19.92 |
| Neuronetics (STIM) | United States | $0.256B | 0.00 |
| 908 Devices (MASS) | United States | $0.253B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| CVRx (CVRX) | United States | $0.202B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.128B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.018B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |